Xiaoxin Wu

5.7k total citations · 1 hit paper
87 papers, 2.5k citations indexed

About

Xiaoxin Wu is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Xiaoxin Wu has authored 87 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 22 papers in Infectious Diseases and 12 papers in Molecular Biology. Recurrent topics in Xiaoxin Wu's work include Influenza Virus Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Respiratory viral infections research (8 papers). Xiaoxin Wu is often cited by papers focused on Influenza Virus Research Studies (19 papers), SARS-CoV-2 and COVID-19 Research (9 papers) and Respiratory viral infections research (8 papers). Xiaoxin Wu collaborates with scholars based in China, United States and Hong Kong. Xiaoxin Wu's co-authors include Lanjuan Li, Hainv Gao, Xiaowei Xu, Yunqing Qiu, Jifang Sheng, Kaijin Xu, Shibo Li, Sheng Zhang, Lingjun Ying and Chunlian Ma and has published in prestigious journals such as Advanced Functional Materials, Brain and Scientific Reports.

In The Last Decade

Xiaoxin Wu

80 papers receiving 2.4k citations

Hit Papers

Clinical findings in a group of patients infected with th... 2020 2026 2022 2024 2020 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
    2020 1.5k citations Xiaowei Xu, Xiaoxin Wu et al. BMJ profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoxin Wu China 18 1.3k 678 486 367 331 87 2.5k
Hongliu Cai China 16 1.6k 1.2× 774 1.1× 318 0.7× 233 0.6× 416 1.3× 51 2.7k
Chen Dong China 22 1.1k 0.8× 488 0.7× 676 1.4× 602 1.6× 231 0.7× 76 2.6k
Yongxi Zhang China 20 2.2k 1.6× 1.1k 1.6× 460 0.9× 267 0.7× 560 1.7× 56 3.0k
Yingzhen Du China 12 1.5k 1.1× 816 1.2× 297 0.6× 277 0.8× 354 1.1× 25 2.3k
Wen Wang China 21 997 0.7× 582 0.9× 295 0.6× 465 1.3× 368 1.1× 72 2.3k
Qinyong Hu China 14 1.6k 1.2× 844 1.2× 237 0.5× 293 0.8× 502 1.5× 35 2.5k
Lei Tu China 20 1.6k 1.2× 863 1.3× 288 0.6× 442 1.2× 547 1.7× 62 3.1k
Jian Wu China 27 1.1k 0.8× 463 0.7× 689 1.4× 580 1.6× 419 1.3× 131 3.1k
Arun Kumar Nalla United States 19 1.7k 1.3× 784 1.2× 337 0.7× 519 1.4× 501 1.5× 26 2.9k

Countries citing papers authored by Xiaoxin Wu

Since Specialization
Citations

This map shows the geographic impact of Xiaoxin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Wu more than expected).

Fields of papers citing papers by Xiaoxin Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoxin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Wu. The network helps show where Xiaoxin Wu may publish in the future.

Co-authorship network of co-authors of Xiaoxin Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoxin Wu. A scholar is included among the top collaborators of Xiaoxin Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoxin Wu. Xiaoxin Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Xiaoxin, et al.. (2025). Potential Roles of Serum Exosomal CD155 and its Impact on NK Cell Immunosuppression in Hepatocellular Carcinoma. Balkan Medical Journal. 42(3). 242–253. 1 indexed citations
2.
3.
4.
Tang, Yang, Zhengyu Zhang, Yue Yu, et al.. (2025). Predictive Model for In-Hospital Death in Older Patients with Type 2 Diabetes Mellitus: A Multicenter Retrospective Study in Southwest China. Diabetes Metabolic Syndrome and Obesity. Volume 18. 1873–1889.
5.
Chen, Jie, et al.. (2024). Neuregulin 1 as a potential biomarker for disease progression in moyamoya disease: A case-control study in Chinese population. Journal of Stroke and Cerebrovascular Diseases. 33(3). 107581–107581. 1 indexed citations
6.
Lu, Fangfang, Zhihao Zhang, Tianxiang Liu, et al.. (2023). A weakly supervised inpainting-based learning method for lung CT image segmentation. Pattern Recognition. 144. 109861–109861. 10 indexed citations
7.
Ye, Fei, Liang Feng, Yuanyuan Dai, et al.. (2023). RNF213 loss-of-function promotes pathological angiogenesis in moyamoya disease via the Hippo pathway. Brain. 146(11). 4674–4689. 34 indexed citations
8.
Dai, Yuanyuan, et al.. (2023). Rnf-213 Knockout Induces Pericyte Reduction and Blood-Brain Barrier Impairment in Mouse. Molecular Neurobiology. 60(11). 6188–6200. 8 indexed citations
9.
Fu, Haijing, et al.. (2023). Severe acute hepatitis of unknown origin in children: Clinical issues of concern. Journal of Translational Internal Medicine. 11(1). 19–23.
10.
Wu, Xiaoxin, et al.. (2022). Monkeypox: Clinical issues of concern. Journal of Translational Internal Medicine. 10(4). 297–299. 1 indexed citations
11.
Jia, Mengyu, et al.. (2021). Changes of antibodies in COVID‑19 patients: A 10‑month prospective study. 42(6). 861–866. 1 indexed citations
12.
Ye, Fei, et al.. (2021). N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosis. Journal of Translational Medicine. 19(1). 316–316. 23 indexed citations
13.
14.
Ni, Qin, Cheng Ding, Yongtao Li, et al.. (2020). Effect of low-to-moderate dose glucocorticoids on viral clearance in COVID-19: a retrospective study. 13(1). 21–24. 4 indexed citations
15.
Xu, Xiaowei, Xiaoxin Wu, Xiangao Jiang, et al.. (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 368. m606–m606. 1497 indexed citations breakdown →
16.
Li, Jiaoxing, Yufang Wang, Jing Lin, et al.. (2019). AND score: a simple tool for predicting infection in acute ischemic stroke patients without a ventilator in the Chinese population. Journal of International Medical Research. 48(3). 1219687855–1219687855. 4 indexed citations
17.
Li, Xiaozhi, Yumin Qiu, Feng Ye, et al.. (2018). A rare case of the dual origin of the right vertebral artery with an aortic arch origin of the left vertebral artery. European Journal of Anatomy. 22(5). 419–423.
18.
Zhang, Yan, Hainv Gao, Weifeng Liang, et al.. (2015). Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study. BMC Infectious Diseases. 16(1). 76–76. 25 indexed citations
19.
Li, Shuangshuang, Xiaoxin Wu, Zhigang Wu, et al.. (2015). Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells. Acta Biochimica et Biophysica Sinica. 47(5). 368–375. 33 indexed citations
20.
Yang, Ence, Heng Wang, Xiaoxin Wu, et al.. (2007). Sequence Characterization, Polymorphism, and Chromosomal Localizations of the Porcine Capz Genes. Biochemical Genetics. 46(1-2). 18–28. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongliu Cai Breakdown of academic impact, for papers by Chen Dong Breakdown of academic impact, for papers by Yongxi Zhang Breakdown of academic impact, for papers by Yingzhen Du Breakdown of academic impact, for papers by Wen Wang Breakdown of academic impact, for papers by Qinyong Hu Breakdown of academic impact, for papers by Lei Tu Breakdown of academic impact, for papers by Jian Wu Breakdown of academic impact, for papers by Arun Kumar Nalla
Rankless by CCL
2026